KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $139,000 | – | 20,432 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vahanian & Associates Financial Planning Inc. | 1,046,484 | $1,266,000 | 1.02% |
| RA Capital Management | 10,874,613 | $13,158,000 | 0.23% |
| Samsara BioCapital, LLC | 601,162 | $727,000 | 0.14% |
| Matisse Capital | 41,400 | $50,000 | 0.04% |
| Manteio Capital LLC | 19,546 | $24,000 | 0.03% |
| Covestor Ltd | 17,766 | $21,000 | 0.03% |
| Knights of Columbus Asset Advisors LLC | 241,857 | $293,000 | 0.02% |
| Virtu Financial LLC | 126,231 | $153,000 | 0.02% |
| Aquatic Capital Management LLC | 6,200 | $8,000 | 0.02% |
| CAXTON CORP | 13,155 | $16,000 | 0.01% |